EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · Real-Time Price · USD
4.170
+0.040 (0.97%)
May 15, 2026, 4:00 PM EDT - Market closed
EDAP TMS Revenue
EDAP TMS had revenue of $15.39M in the quarter ending March 31, 2026, with 16.68% growth. This brings the company's revenue in the last twelve months to $64.25M, up 2.97% year-over-year. In the year 2025, EDAP TMS had annual revenue of $60.11M, down -9.86%.
Revenue (ttm)
$64.25M
Revenue Growth
+2.97%
P/S Ratio
2.12
Revenue / Employee
$238,942
Employees
310
Market Cap
156.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 60.11M | -6.58M | -9.86% |
| Dec 31, 2024 | 66.69M | 6.27M | 10.37% |
| Dec 31, 2023 | 60.42M | 5.32M | 9.64% |
| Dec 31, 2022 | 55.11M | 11.05M | 25.07% |
| Dec 31, 2021 | 44.06M | 2.41M | 5.79% |
| Dec 31, 2020 | 41.65M | -3.21M | -7.16% |
| Dec 31, 2019 | 44.86M | 5.70M | 14.54% |
| Dec 31, 2018 | 39.16M | 3.48M | 9.74% |
| Dec 31, 2017 | 35.69M | 107.00K | 0.30% |
| Dec 31, 2016 | 35.58M | 3.36M | 10.43% |
| Dec 31, 2015 | 32.22M | 5.97M | 22.73% |
| Dec 31, 2014 | 26.25M | 2.19M | 9.09% |
| Dec 31, 2013 | 24.07M | -1.95M | -7.51% |
| Dec 31, 2012 | 26.02M | 3.75M | 16.82% |
| Dec 31, 2011 | 22.27M | -930.00K | -4.01% |
| Dec 31, 2010 | 23.20M | -1.64M | -6.59% |
| Dec 31, 2009 | 24.84M | 1.98M | 8.68% |
| Dec 31, 2008 | 22.86M | 643.00K | 2.89% |
| Dec 31, 2007 | 22.21M | 2.04M | 10.11% |
| Dec 31, 2006 | 20.17M | -778.00K | -3.71% |
| Dec 31, 2005 | 20.95M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 403.43B |
| Cencora | 328.68B |
| Cardinal Health | 250.74B |
| Henry Schein | 13.38B |
| Accendra Health | 2.72B |
| 111, Inc. | 1.80B |
| Cosmos Health | 65.27M |
| Synergy CHC | 30.38M |
EDAP News
- 16 hours ago - Telix announces LoI to collaborate with EDAP TMS and Profound Medical - TheFly
- 1 day ago - EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer - GlobeNewsWire
- 2 days ago - EDAP | Focal One to Host Investor Day on June 1, 2026 - GlobeNewsWire
- 8 days ago - EDAP TMS Earnings Call Transcript: Q1 2026 - Transcripts
- 8 days ago - EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue - GlobeNewsWire
- 15 days ago - EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer - GlobeNewsWire
- 4 weeks ago - EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026 - GlobeNewsWire
- 5 weeks ago - EDAP TMS price target lowered to $10 from $14 at H.C. Wainwright - TheFly